Factors Associated with Intention to Initiate Pre-exposure Prophylaxis in Cisgender Women at High Behavioral Risk for HIV in Washington, D.C.


Journal

Archives of sexual behavior
ISSN: 1573-2800
Titre abrégé: Arch Sex Behav
Pays: United States
ID NLM: 1273516

Informations de publication

Date de publication:
07 2022
Historique:
received: 13 11 2020
accepted: 20 12 2021
revised: 16 12 2021
pubmed: 28 5 2022
medline: 22 7 2022
entrez: 27 5 2022
Statut: ppublish

Résumé

Pre-exposure prophylaxis (PrEP) for HIV prevention is underutilized by cisgender women at risk for HIV in the USA. Published research on PrEP initiation among cisgender women at risk for HIV focuses on identifying barriers and facilitators associated with intention to initiate, but few apply a behavioral theoretical lens to understand the relative importance of these diverse factors. This study provides a theoretically grounded view of the relative importance of factors associated with intention to initiate PrEP. We conducted an anonymous, cross-sectional survey of 1437 cisgender women seeking care at family planning and sexual health clinics to evaluate hypothesized barriers and facilitators of PrEP initiation. We categorized cisgender women with ≥ 3 behavioral risk-factors as "high-risk" for HIV acquisition; 26.9% (N = 387) met high-risk criterion. Among cisgender women in the high-risk sample, the majority were Black and single. Perceived risk of HIV acquisition was low and 13.7% reported intention to initiate PrEP. Positive attitudes toward PrEP, self-efficacy, perceived support from medical providers and social networks, and prior discussion about PrEP with medical providers were associated with intention to initiate PrEP; stigma was negatively associated. Background characteristics (other than age), risk factors for HIV acquisition, prior awareness of PrEP, and perceived risk of HIV were not associated with uptake intention. These findings support interventions that center on the role of providers in the provision of PrEP and on social networks in destigmatization of PrEP use.

Identifiants

pubmed: 35622077
doi: 10.1007/s10508-021-02274-4
pii: 10.1007/s10508-021-02274-4
pmc: PMC9308717
mid: NIHMS1822556
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2613-2624

Subventions

Organisme : NIDA NIH HHS
ID : K01 DA050496
Pays : United States
Organisme : NIDA NIH HHS
ID : R25 DA028567
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001409
Pays : United States

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

J AIDS Clin Res. 2015 Nov;6(11):1-10
pubmed: 27019765
Ann Epidemiol. 2018 Dec;28(12):850-857.e9
pubmed: 29941379
AIDS Behav. 2021 Feb;25(2):582-591
pubmed: 32886220
AIDS. 2013 Aug 24;27(13):2155-60
pubmed: 24384592
AIDS Patient Care STDS. 2018 Dec;32(12):490-494
pubmed: 30036080
Stigma Health. 2020 May;5(2):240-246
pubmed: 33184608
N Engl J Med. 2012 Aug 2;367(5):399-410
pubmed: 22784037
J Acquir Immune Defic Syndr. 2020 Apr 15;83(5):450-456
pubmed: 31939870
Psychol Health. 2011 Sep;26(9):1113-27
pubmed: 21929476
Int J Womens Health. 2017 May 31;9:391-401
pubmed: 28615975
J Assoc Nurses AIDS Care. 2018 Jan - Feb;29(1):83-92
pubmed: 29274655
J Acquir Immune Defic Syndr. 2013 Jun 1;63 Suppl 1:S95-101
pubmed: 23673895
N Engl J Med. 2012 Aug 2;367(5):423-34
pubmed: 22784038
Psychol Bull. 2001 Jan;127(1):142-61
pubmed: 11271752
AIDS Behav. 2017 Aug;21(8):2261-2269
pubmed: 28409266
J Natl Med Assoc. 2018 Oct;110(5):480-485
pubmed: 30129509
J Acquir Immune Defic Syndr. 2018 Sep 1;79(1):46-53
pubmed: 29847480
J AIDS Clin Res. 2017 Sep;8(9):
pubmed: 29201531
Curr HIV Res. 2013 Oct;11(7):543-8
pubmed: 24476352
J Acquir Immune Defic Syndr. 2020 Aug 15;84(5):497-507
pubmed: 32692108
J Racial Ethn Health Disparities. 2020 Jun;7(3):550-554
pubmed: 31848943
Health Psychol. 2012 Jan;31(1):114-21
pubmed: 21767018
AIDS Behav. 2017 May;21(5):1256-1267
pubmed: 27885552
AIDS Behav. 2018 Nov;22(11):3576-3587
pubmed: 29468493
Am J Health Promot. 1996 Nov-Dec;11(2):87-98
pubmed: 10163601
Arch Sex Behav. 2020 Aug;49(6):2205-2212
pubmed: 32274742
AIDS Care. 2022 Mar;34(3):273-283
pubmed: 33719816
J Health Commun. 2017 Mar;22(3):183-189
pubmed: 28248625
Sex Transm Dis. 2020 Feb;47(2):96-99
pubmed: 31651712
AIDS Care. 2017 Jun;29(6):751-758
pubmed: 27680304
J Acquir Immune Defic Syndr. 2019 Apr 15;80(5):527-532
pubmed: 30649036
AIDS Patient Care STDS. 2019 Sep;33(9):384-387
pubmed: 31339737
Curr Opin HIV AIDS. 2016 Jan;11(1):67-73
pubmed: 26599165
AIDS Patient Care STDS. 2020 Jun;34(6):259-266
pubmed: 32484743
AIDS Educ Prev. 2012 Oct;24(5):408-21
pubmed: 23016502
Arch Sex Behav. 2020 Aug;49(6):2213-2221
pubmed: 32270399
Ann Behav Med. 2016 Aug;50(4):592-612
pubmed: 27169555
AIDS Patient Care STDS. 2015 Feb;29(2):102-10
pubmed: 25513954
Womens Health Issues. 2019 Jan - Feb;29(1):3-7
pubmed: 30292440
J Womens Health (Larchmt). 2019 Sep;28(9):1272-1285
pubmed: 31180253
AIDS Behav. 2019 Oct;23(10):2741-2748
pubmed: 31065923
AIDS Patient Care STDS. 2018 Jan;32(1):16-23
pubmed: 29323558
AIDS Care. 2021 Feb;33(2):239-243
pubmed: 32449402
AIDS Behav. 2019 Jul;23(7):1737-1748
pubmed: 30264207
AIDS Behav. 2016 Jul;20(7):1443-50
pubmed: 27115399
Br J Soc Psychol. 2001 Dec;40(Pt 4):471-99
pubmed: 11795063
Ann Epidemiol. 2017 Apr;27(4):238-243
pubmed: 28325538
Arch Sex Behav. 2021 May;50(4):1713-1728
pubmed: 34075504

Auteurs

Rachel K Scott (RK)

MedStar Health Research Institute, 6525 Belcrest Road, Hyattsville, MD, 20782, USA. Rachel.k.scott@medstar.net.
MedStar Washington Hospital Center, Washington, DC, USA. Rachel.k.scott@medstar.net.

Shawnika J Hull (SJ)

Department of Communication, Rutgers University, New Brunswick, NJ, USA.

Jim C Huang (JC)

Department of Business Management, National Sun Yat-sen University, Kaohsiung, Taiwan.

Megan Coleman (M)

DC Health, Washington, DC, USA.

Peggy Ye (P)

MedStar Washington Hospital Center, Washington, DC, USA.

Pam Lotke (P)

MedStar Washington Hospital Center, Washington, DC, USA.

Jason Beverley (J)

DC Health, Washington, DC, USA.

Patricia Moriarty (P)

MedStar Health Research Institute, 6525 Belcrest Road, Hyattsville, MD, 20782, USA.

Dhikshitha Balaji (D)

MedStar Health Research Institute, 6525 Belcrest Road, Hyattsville, MD, 20782, USA.

Allison Ward (A)

MedStar Health Research Institute, 6525 Belcrest Road, Hyattsville, MD, 20782, USA.
MedStar Washington Hospital Center, Washington, DC, USA.

Jennifer Holiday (J)

MedStar Health Research Institute, 6525 Belcrest Road, Hyattsville, MD, 20782, USA.

Ashley R Brant (AR)

Women's Health Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.

Martha Cameron (M)

International Community of Women Living with HIV, Washington, DC, USA.

Rick Elion (R)

DC Health, Washington, DC, USA.

Adam Visconti (A)

MedStar Georgetown University, NW Washington, DC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH